Valvular heart interventions: advances from 2019 to 2020.

Valvular heart interventions: advances from 2019 to 2020. EuroIntervention. 2020 Sep 22;: Authors: Wang R, Gao C, Kawashima H, Modolo R, Rosseel L, Onuma Y, Soliman O, Serruys PW, Mylotte D Abstract Valvular heart disease (VHD) remains a major societal and economic burden worldwide. Percutaneous valve technologies have revolutionized the treatment of VHD and emerged as an alternative treatment option in elderly patients at all levels of surgical risk. In 2019 and 2020, various new and improved transcutaneous treatment technologies for the treatment of VHD have emerged, as well as some important landmark trials were published. In this review, we present the most recent and relevant studies that emerged on the transcatheter treatment of VHD in 2019 and 2020. PMID: 32958460 [PubMed - as supplied by publisher]
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research